Merck & Co. Statistics

Total Valuation

Merck & Co. has a market cap or net worth of CAD 343.12 billion. The enterprise value is 375.31 billion.

Market Cap	343.12B
Enterprise Value	375.31B

Important Dates

The next estimated earnings date is Tuesday, February 3, 2026.

Earnings Date	Feb 3, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.91%
Shares Change (QoQ)	-0.60%
Owned by Insiders (%)	0.05%
Owned by Institutions (%)	79.34%
Float	2.48B

Valuation Ratios

The trailing PE ratio is 12.94 and the forward PE ratio is 11.12.

PE Ratio	12.94
Forward PE	11.12
PS Ratio	3.83
PB Ratio	4.75
P/TBV Ratio	16.48
P/FCF Ratio	18.88
P/OCF Ratio	14.44
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.49, with an EV/FCF ratio of 20.65.

EV / Earnings	14.16
EV / Sales	4.21
EV / EBITDA	8.49
EV / EBIT	9.96
EV / FCF	20.65

Financial Position

The company has a current ratio of 1.66, with a Debt / Equity ratio of 0.80.

Current Ratio	1.66
Quick Ratio	1.09
Debt / Equity	0.80
Debt / EBITDA	1.30
Debt / FCF	3.17
Interest Coverage	21.34

Financial Efficiency

Return on equity (ROE) is 39.49% and return on invested capital (ROIC) is 19.31%.

Return on Equity (ROE)	39.49%
Return on Assets (ROA)	13.76%
Return on Invested Capital (ROIC)	19.31%
Return on Capital Employed (ROCE)	26.94%
Revenue Per Employee	1.21M
Profits Per Employee	358,274
Employee Count	75,000
Asset Turnover	0.52
Inventory Turnover	2.24

Taxes

In the past 12 months, Merck & Co. has paid 3.86 billion in taxes.

Income Tax	3.86B
Effective Tax Rate	12.71%

Stock Price Statistics

Beta (5Y)	0.30
52-Week Price Change	n/a
50-Day Moving Average	20.57
200-Day Moving Average	19.40
Relative Strength Index (RSI)	58.39
Average Volume (20 Days)	9,949

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.09

Income Statement

In the last 12 months, Merck & Co. had revenue of CAD 89.47 billion and earned 26.51 billion in profits. Earnings per share was 10.52.

Revenue	89.47B
Gross Profit	69.66B
Operating Income	37.87B
Pretax Income	30.39B
Net Income	26.51B
EBITDA	43.91B
EBIT	37.87B
Earnings Per Share (EPS)	10.52

Full Income Statement

Balance Sheet

The company has 25.37 billion in cash and 57.63 billion in debt, giving a net cash position of -32.26 billion.

Cash & Cash Equivalents	25.37B
Total Debt	57.63B
Net Cash	-32.26B
Net Cash Per Share	n/a
Equity (Book Value)	72.30B
Book Value Per Share	29.04
Working Capital	26.37B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 23.77 billion and capital expenditures -5.59 billion, giving a free cash flow of 18.18 billion.

Operating Cash Flow	23.77B
Capital Expenditures	-5.59B
Free Cash Flow	18.18B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 77.85%, with operating and profit margins of 42.33% and 29.63%.

Gross Margin	77.85%
Operating Margin	42.33%
Pretax Margin	33.96%
Profit Margin	29.63%
EBITDA Margin	49.07%
EBIT Margin	42.33%
FCF Margin	20.31%

Dividends & Yields

Merck & Co. does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	42.60%
Buyback Yield	0.91%
Shareholder Yield	0.91%
Earnings Yield	7.73%
FCF Yield	5.30%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Merck & Co. has an Altman Z-Score of 3.89 and a Piotroski F-Score of 5.

Altman Z-Score	3.89
Piotroski F-Score	5